Literature DB >> 1584801

Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor.

D M Ignar-Trowbridge1, K G Nelson, M C Bidwell, S W Curtis, T F Washburn, J A McLachlan, K S Korach.   

Abstract

Epidermal growth factor (EGF) reproduces many of the effects of estrogen on the murine female reproductive tract and may partially mediate estrogen-induced growth and differentiation. This study was performed to investigate the mechanism by which EGF elicits estrogen-like actions in the whole animal. EGF was administered to adult ovariectomized mice by slow release pellets implanted under the kidney capsule. The induction of uterine DNA synthesis and phosphatidylinositol lipid turnover by EGF or administration of diethylstilbestrol (5 micrograms/kg), a potent estrogen, was attenuated by the estrogen receptor antagonist ICI 164,384. Furthermore, EGF mimicked the effects of estrogen on enhanced nuclear localization of the estrogen receptor and the formation of a unique form of the estrogen receptor found exclusively in the nucleus. These results suggest that EGF may induce effects similar to those of estrogen in the mouse uterus by an interaction between the EGF signaling pathway and the classical estrogen receptor. The demonstration of cross-talk between polypeptide growth factors and steroid hormone receptors may be of importance to our understanding of the regulation of normal growth and differentiation as well as the mechanisms of transmission of extracellular mitogen signals to the nucleus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1584801      PMCID: PMC49142          DOI: 10.1073/pnas.89.10.4658

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/threonine protein kinase.

Authors:  A J Rossomando; D M Payne; M J Weber; T W Sturgill
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

2.  Regulation of uterine epidermal growth factor (EGF) receptors by estrogen in the mature rat and during the estrous cycle.

Authors:  R M Gardner; G Verner; J L Kirkland; G M Stancel
Journal:  J Steroid Biochem       Date:  1989-03       Impact factor: 4.292

3.  EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling.

Authors:  B Margolis; S G Rhee; S Felder; M Mervic; R Lyall; A Levitzki; A Ullrich; A Zilberstein; J Schlessinger
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

4.  Regulation of progesterone receptor-mediated transcription by phosphorylation.

Authors:  L A Denner; N L Weigel; B L Maxwell; W T Schrader; B W O'Malley
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

5.  Diethylstilbestrol stimulates persistent phosphatidylinositol lipid turnover by an estrogen receptor-mediated mechanism in immature mouse uterus.

Authors:  D M Ignar-Trowbridge; A R Hughes; J W Putney; J A McLachlan; K S Korach
Journal:  Endocrinology       Date:  1991-11       Impact factor: 4.736

6.  Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid.

Authors:  R P DiAugustine; P Petrusz; G I Bell; C F Brown; K S Korach; J A McLachlan; C T Teng
Journal:  Endocrinology       Date:  1988-06       Impact factor: 4.736

7.  Nuclear estrogen receptor molecular heterogeneity in the mouse uterus.

Authors:  T S Golding; K S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

8.  The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue.

Authors:  M K Gibson; L A Nemmers; W C Beckman; V L Davis; S W Curtis; K S Korach
Journal:  Endocrinology       Date:  1991-10       Impact factor: 4.736

9.  Regulation of epidermal growth factor receptor by estrogen.

Authors:  V R Mukku; G M Stancel
Journal:  J Biol Chem       Date:  1985-08-15       Impact factor: 5.157

10.  Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid.

Authors:  R B Lingham; G M Stancel; D S Loose-Mitchell
Journal:  Mol Endocrinol       Date:  1988-03
View more
  108 in total

1.  Influence of antiestrogens on EGF- and IGF-I-mediated proliferation of human breast cancer cells.

Authors:  G M Tong; T T Rajah; J T Pento
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-01       Impact factor: 2.416

Review 2.  Mammary gland growth and development from the postnatal period to postmenopause: ovarian steroid receptor ontogeny and regulation in the mouse.

Authors:  J L Fendrick; A M Raafat; S Z Haslam
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

Review 3.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

4.  Antiestrogen inhibition of EGF-mediated invasiveness of human breast cancer cells.

Authors:  G M Tong; T T Rajah; X Zang; J T Pento
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-10       Impact factor: 2.416

5.  Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor.

Authors:  D C Márquez; J Lee; T Lin; R J Pietras
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

6.  Signaling themes shared between peptide and steroid hormones at the plasma membrane.

Authors:  C S Watson
Journal:  Sci STKE       Date:  1999-12-14

7.  Combined effect of xenoestrogens and growth factors in two estrogen-responsive cell lines.

Authors:  Louis J Cossette; Isabelle Gaumond; Maria-Grazia Martinoli
Journal:  Endocrine       Date:  2002-08       Impact factor: 3.633

Review 8.  Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling.

Authors:  Paul H Driggers; James H Segars
Journal:  Trends Endocrinol Metab       Date:  2002-12       Impact factor: 12.015

Review 9.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

10.  Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.

Authors:  Jian-Hua Zhou; David V Yu; Jingwei Cheng; David J Shapiro
Journal:  Steroids       Date:  2007-07-07       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.